Results 151 to 160 of about 8,311 (216)

Long-term follow-up of venetoclax monotherapy in previously treated patients with Waldenström macroglobulinemia. [PDF]

open access: yesBlood Adv
Castillo JJ   +14 more
europepmc   +1 more source

Outcomes after transition from ibrutinib to zanubrutinib in patients with Waldenström macroglobulinemia from the ASPEN study. [PDF]

open access: yesBlood Adv
García-Sanz R   +15 more
europepmc   +1 more source

Ibrutinib plus rituximab vs ibrutinib monotherapy in patients with Waldenström macroglobulinemia: a pooled analysis. [PDF]

open access: yesBlood Adv
Guijosa A   +6 more
europepmc   +1 more source

Waldenstrom’s Macroglobulinemia

open access: yes, 2018
Treon, S.P., Merlini, G., Dimopoulos, M.
openaire   +1 more source

Home - About - Disclaimer - Privacy